Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CHRNB2 Mouse anti-Human, Clone:2D12A2, Abnova™

Mouse monoclonal antibody raised against recombinant human CHRNB2.

Supplier:  Abnova Corporation MAB17554

Catalog No. 89-333-978


Only null left
Add to Cart

Description

Description

Neuronal acetylcholine receptors are homo- or heteropentameric complexes composed of homologous alpha and beta subunits. They belong to a superfamily of ligand-gated ion channels which allow the flow of sodium and potassium across the plasma membrane in response to ligands such as acetylcholine and nicotine. This gene encodes one of several beta subunits. Mutations in this gene are associated with autosomal dominant nocturnal frontal lobe epilepsy. [provided by RefSeq]
Specifications

Specifications

CHRNB2
Monoclonal
Unconjugated
ELISA (1:10000)
Western Blot (1:500-1:2000)
Immunocytochemistry
Flow Cytometry (1:200-1:400)
Immunohistochemistry
The optimal working dilution should be determined by the end user.
CHRNB2
Mouse
100 μg
Human
Antibody
IgG2a
ELISA, Flow Cytometry, Western Blot
2D12A2
cholinergic receptor, nicotinic, beta 2 (neuronal)
In PBS (0.05% sodium azide)
EFNL3, nAChRB2
Recombinant protein corresponding to amino acid 26-233 of human CHRNB2 from E. coli.
1141
Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.